Back to news archive
Image for Successful pre-clinical testing of QuickMIC® in the US
News 2024-01-19

Successful pre-clinical testing of QuickMIC® in the US

Today we announce the successful completion of our pre-clinical testing of the QuickMIC® system in the US. The evaluation of our QuickMIC® system showed excellent performance and holds promises for the upcoming FDA study. Results from the US pre-clinical study will be presented at significant microbiology conferences during the next year.

This pre-clinical testing included about a hundred clinical patient samples and was performed at two reputable US clinical laboratories.

To press release

Gradientech is an ISO13485 certified company since 2017

Contact

Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala
Sweden

sales@gradientech.se

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2024 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book